INHALT

Commission Implementing Decision (EU) 2020/1729 of 17 November 2020 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria and repealing Implementing Decision 2013/652/EU (notified under document C(2020) 7894) (Only the English version is authentic) (Text with EEA relevance)

COMMISSION IMPLEMENTING DECISION (EU) 2020/1729
of 17 November 2020
on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria and repealing Implementing Decision 2013/652/EU
(notified under document C(2020) 7894)
(Only the English version is authentic)
(Text with EEA relevance)
Article 1
Subject matter and scope
Article 2
Definitions
Article 3
Sampling framework and analysis
Article 4
Annual AMR reporting and assessment
Article 5
Publication of the data
Article 6
Repeal
Article 7
Application
Article 8
Addressees
ANNEX
PART A
Sampling framework and analysis
1.
Origin of bacterial isolates subject to antimicrobial susceptibility testing
2.
Sampling frequency
3.
Sampling design and sample size
3.1.
At slaughterhouse level
(a) Sampling design:
(b) Sample size:
3.2.
At retail level
(a) Sampling design:
(b) Sample size:
3.3.
At border control posts
(a) Sampling design:
(b) Sample size:
4.
Antimicrobial susceptibility testing
4.1.
Number of isolates to be tested
4.2.
Analytical methods for detection and antimicrobial susceptibility testing
5.
Specific monitoring of ESBL- or AmpC- or CP-producing
E. coli
5.1.
Methods for detection of presumptive ESBL- or AmpC- or CP-producing E. coli
5.2.
Quantitative method to assess the proportion of ESBL- or AmpC-producing E. coli
6.
Alternative method
7.
Quality control, storage of the isolates and confirmatory testing
PART B
Reporting
1.
General provisions for reporting of the data
2.
Reporting dataset
2.1.
Reporting antimicrobial susceptibility testing results
2.2.
Reporting WGS testing results